Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 174074-88-5 | MDL No. : | MFCD12031312 |
Formula : | C10H8N2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CZKCZHGGECJJMQ-UHFFFAOYSA-N |
M.W : | 220.18 | Pubchem ID : | 21505196 |
Synonyms : |
|
Num. heavy atoms : | 16 |
Num. arom. heavy atoms : | 10 |
Fraction Csp3 : | 0.1 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 56.47 |
TPSA : | 92.02 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.2 cm/s |
Log Po/w (iLOGP) : | 1.34 |
Log Po/w (XLOGP3) : | 0.62 |
Log Po/w (WLOGP) : | 0.0 |
Log Po/w (MLOGP) : | 0.58 |
Log Po/w (SILICOS-IT) : | 2.05 |
Consensus Log Po/w : | 0.92 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.93 |
Solubility : | 2.61 mg/ml ; 0.0119 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.13 |
Solubility : | 1.64 mg/ml ; 0.00746 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.23 |
Solubility : | 0.131 mg/ml ; 0.000593 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.79 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
59% | Stage #1: Heating / reflux Stage #2: With sodium hydrogencarbonate In dichloromethane; water at 20℃; for 1 h; |
To a 250 mL flask charged with methyl 2,4-dihydroxyquinazoline-7-carboxylate was added POCI3(76 mL), PCI5 (12.1 g, 58.1 mmol), and the suspension heated at reflux overnight under nitrogen. In morning a dark orange solution has formed. The POCI3 was removed and the residue azeotroped with toluene to yield an orange solid that was taken into DCM (50 mL) and added slowly to stirred satd NaHCO3 (300 mL). The bi-phasic solution was then diluted with DCM (100 mL) and water (30 mL) and stirred for 1 hour at room temp. DCM (500 mL) was added and the mix transferred to a sep-funnel. The DCM layer was removed along with a large amount of ppt. The aq. was extracted with DCM ( 3 x 100 mL) and the combined organics dried over MgSO4, filtered and stripped to a orange solid that was purified by Biotage 65 flash chromatography eluting with DCM - 3percent MeOH/DCM over 3.5 L to reveal the title compound as a white solid, 4.4 g, 59percent.1H NMR (400 MHz, DMSO-D6) δ ppm 8.47 (1 H, d, J=1.01 Hz) 8.43 (1 H, d, J=8.84 Hz) 8.29 (1 H, dd, J=8.72, 1.64 Hz) 3.96 (3 H, s); MS (API+) for C10H6N2CI2O2 m/z 257.0 (M+H)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
80% | at 200℃; for 3 h; | Step 1: 2,4-Dioxo-l,2,3,4-tetrahydro-quinazoline-7-carboxylic acid methyl esterTo a 250 mL round bottom flask, 2-amino dimethyl terephthalate (3 g, 0.0143 mol) and urea (4.3 g, 0.0717 mol) were added. The reaction mixture was stirred at 200°C for 3 h. The reaction mixture was allowed to reach 100 °C and water was added. The aqueous reaction mixture was stirred at 100°C for 5-10 min then allowed to reach room temperature. The solid was filtered, washed with chloroform dried and azeotroped with toluene to afford the title compound [2.5 g, 80percent]. This material was taken to the next step without any further purification. 1H NMR; (400 MHz, DMSO-d6): δ 11.25 (brs, 2H), 7.98 (d, 1H, J= 8.2 Hz), 7.78 (s, 1H), 7.65 (d, J= 8.2, 1.2 Hz, 1H), 3.98 (s, 3H): LC-MS (ESI): Calculated mass: 220.0; Observed mass: 221.0 [M+H]+ (RT: 0.19 min) |
[ 61948-86-5 ]
5-Methoxyquinazoline-2,4(1H,3H)-dione
Similarity: 0.83
[ 860187-45-7 ]
Methyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate
Similarity: 0.82
[ 3814-10-6 ]
Methyl 4-(phenylcarbamoyl)benzoate
Similarity: 0.82
[ 59674-85-0 ]
7-Aminoquinazoline-2,4(1H,3H)-dione
Similarity: 0.81
[ 860187-45-7 ]
Methyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylate
Similarity: 0.82
[ 3814-10-6 ]
Methyl 4-(phenylcarbamoyl)benzoate
Similarity: 0.82
[ 106429-57-6 ]
Methyl 2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylate
Similarity: 0.78
[ 301533-59-5 ]
Methyl 4-butyramido-3-methylbenzoate
Similarity: 0.76
[ 5395-36-8 ]
Ethyl 6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate
Similarity: 0.75
[ 61948-86-5 ]
5-Methoxyquinazoline-2,4(1H,3H)-dione
Similarity: 0.83
[ 59674-85-0 ]
7-Aminoquinazoline-2,4(1H,3H)-dione
Similarity: 0.81
[ 67449-23-4 ]
8-Methylquinazoline-2,4(1H,3H)-dione
Similarity: 0.80
[ 604-50-2 ]
1-Methylquinazoline-2,4(1H,3H)-dione
Similarity: 0.77